TEVA PHARMACEUTICAL INDUSTRIES LTD Balance Sheet
TEVA / Health Care|12 years of annual SEC 10-K data (FY2014-FY2025)
Shows total assets, cash and equivalents, receivables, property and equipment, total debt, and shareholders' equity across 12 fiscal years. All figures from audited SEC 10-K filings.
TEVA PHARMACEUTICAL INDUSTRIES LTD had $40.7B in total assets and $7.9B in shareholders' equity as of FY2025.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score 0.41 (distress zone, below 1.8 threshold)
- Negative profit margin: -9.9%
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $3.6B | $3.3B | $3.2B | $2.8B | $2.2B | $2.2B | $2.0B | $1.8B | $963.0M | $988.0M | $6.9B | $2.2B |
| Accounts Receivable | $3.7B | $3.1B | $3.4B | $3.7B | $4.5B | $4.6B | $5.7B | $5.8B | $7.1B | $7.5B | - | - |
| Inventory | $3.2B | $3.0B | $4.0B | $3.8B | $3.8B | $4.4B | $4.4B | $4.7B | $4.9B | $5.0B | - | - |
| Current Assets | $13.9B | $12.6B | $12.5B | $12.1B | $12.6B | $13.0B | $13.5B | $13.8B | $15.4B | $17.2B | - | - |
| PP&E (Net) | $4.1B | $4.6B | $5.8B | $5.7B | $6.0B | $6.3B | $6.4B | $6.9B | $7.7B | $8.1B | - | - |
| Goodwill | $16.0B | $15.1B | $17.2B | $17.2B | $17.6B | $20.6B | $24.8B | $24.9B | $28.4B | $44.4B | $19.0B | - |
| Total Assets | $40.7B | $39.3B | $43.5B | $45.9B | $47.7B | $50.6B | $57.5B | $60.7B | $70.6B | $93.1B | - | - |
| Current Liabilities | $13.5B | $12.8B | $12.2B | $11.5B | $11.0B | $13.2B | $13.7B | $14.3B | $17.9B | $18.5B | - | - |
| Total Debt | - | - | - | - | - | - | - | - | $28.8B | $32.5B | - | - |
| Shareholders' Equity | $7.9B | $5.4B | $7.5B | $7.8B | $10.3B | $10.0B | $14.0B | $14.7B | $18.7B | $35.0B | $29.9B | $23.4B |